$38.19
0.040.10%
At Close: -
$37.00
-1.19-3.12%
After Hours: 6:38 PM EDT
15 minutes delayed
Comments
Loading...
Calliditas Therapeutics
CALTNASDAQ
Latest news for Calliditas Therapeutics (NASDAQ:CALT) Stock
Calliditas Therapeutics Stock (NASDAQ: CALT)
Categories: All
Friday, July 26, 2024
Friday, July 05, 2024
Tuesday, June 18, 2024
Friday, May 31, 2024
Tuesday, May 28, 2024
- Jefferies Downgrades Calliditas Therapeutics ...
- Crude Oil Rises Sharply; Elbit Systems Shares Fall After Q1 Results
- Stifel Downgrades Calliditas Therapeutics to ...
- Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics, Enhancing Pharma Growth Strategy
- Dow Dips Over 100 Points; GameStop Shares Spike higher
- HC Wainwright & Co. Downgrades Calliditas The...
- Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Why GameStop Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
- Calliditas Therapeutics shares are trading hi...
- Calliditas Therapeutics Board Unanimously Rec...
Friday, May 24, 2024
Thursday, May 23, 2024
Tuesday, May 14, 2024
Monday, May 06, 2024
Monday, April 29, 2024
Wednesday, April 24, 2024
Thursday, April 18, 2024
Monday, April 08, 2024
Tuesday, March 12, 2024
Wednesday, March 06, 2024
Thursday, February 22, 2024
Wednesday, February 21, 2024
Tuesday, February 13, 2024
Friday, January 26, 2024
Monday, January 08, 2024
Thursday, December 28, 2023
Thursday, December 21, 2023
- Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- Calliditas Therapeutics shares are trading hi...
- Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
- Micron Posts Upbeat Sales, Joins Calliditas Therapeutics And Other Big Stocks Moving Higher In Thursday's Pre-Market Session